The interaction between causative genes and diet is known to influence the onset of obesity and diabetes in humans, although it has remained difficult to identify diabetogenic gene(s) because humans are genetically and environmentally heterogeneous. Mouse SMXA recombinant inbred (RI) strains are established from parental inbred strains (SM/J and A/J) and have been shown to be beneficial tools for analyzing polygenic traits. We previously mapped a significant quantitative trait locus (QTL, T2dm1sa ) on Chromosome (Chr.) 10 and suggestive QTLs on Chr. 2, 6, and 18 for diabetes-related traits by using SMXA RI strains fed a high-carbohydrate diet. As a first step in identifying the responsible gene among QTLs for glucose tolerance mapped on Chr. 10 and 18, we established new strains of A.SM-T2dm1sa and SM.A-D18Mit19-D18Mit7 congenic mice. Each congenic strain bears the diabetogenic allele of an introgressed chromosomal region on a genetic background strain carrying the non-diabetogenic allele. The diabetogenic effect of T2dm1sa mapped on Chr. 10 was not supported by studies of A.SM-T2dm1sa congenic mice when the mice were fed a high-carbohydrate or high-fat diet. SM.A-D18Mit19-D18Mit7 congenic mice showed impaired glucose tolerance not only when they were fed a high-carbohydrate diet, but also when they were fed a high-fat diet. Thus, it appears that gene(s) affecting diabetes-related traits under either dietary condition may be present on Chr. 18. Key Words congenic, quantitative trait locus, high-fat diet, recombinant inbred
The prevalence of obesity and diabetes has increased worldwide ( 1 ) . The interaction between genes and diet is known to exert an influence on the pathogenicity of obesity and diabetes in humans ( 2 -4 ) . However, it should be noted that the increasing incidence of obesity and diabetes is not due to changes in genetic factors in populations, but rather to environmental factors such as changes in lifestyle (e.g., changes in diet and levels of activity) ( 5 ) . A high percentage of dietary fat has been associated with the conversion of impaired glucose tolerance to overt type 2 diabetes in humans ( 6 , 7 ). Petro and co-workers ( 8 ) reported that a high percentage of dietary fat is a crucial stimulus for obesity and diabetes in C57BL/6 mice, a model for diet-induced diabetes and obesity. Using this mouse model, they demonstrated that dietary fat is a critical factor in the development and maintenance of obesity and type 2 diabetes. Therefore, it is of value to analyze diabetogenic gene(s) while considering dietary content such as fat intake. It is difficult to identify diabetogenic gene(s) in humans due to genetic heterogeneity, and dietary factors cannot be easily controlled. However, using inbred animal models, it becomes possible to strictly control genetic and environmental factors.
Recombinant inbred strains are derived from two different parental inbred strains and are beneficial tools for analyzing polygenic traits. Mouse SMXA recombinant inbred (SMXA RI) strains have been established from the SM/J and A/J strains by Nishimura and collaborators ( 9 ) . In a previous study, we performed quantitative trait locus (QTL) analysis of diabetes-related traits in 19 SMXA RI strains fed a high-carbohydrate diet ( 10 ) . We mapped a significant QTL ( T2dm1sa ; Type 2 diabetes mellitus 1 in smxa ) on Chromosome (Chr.) 10 and suggestive QTLs on Chr. 2, 6, and 18 ( 10 ). On the distal region of Chr. 10, the SM/J allele of T2dm1sa was associated with increased free-fed blood glucose concentrations and increased blood glucose concentrations at 120 min during an intraperitoneal glucose tolerance test (IPGTT). On the proximal region of Chr. 2, a suggestive QTL for glucose tolerance (blood glucose concentration at 30 min during IPGTT) was detected. On the central region of Chr. 6, QTLs for BMI and free-fed blood glucose concentration were detected. On the proximal and central region of Chr. 18, QTLs for free-fed blood glucose concentrations, fasting blood glucose concentrations, and blood glucose concentration at 120 min during IPGTT were detected. On Chr. 2, 6, and 18, the A/J-derived allele is associated with increased BMI, increased free-fed blood glucose concentrations, and impaired glucose tolerance.
To initially identify the molecular basis of QTLs for glucose tolerance mapped on Chr. 2, 10, and 18, we constructed three congenic strains. Each congenic strain carried the diabetogenic allele on the genetic background strain carrying the non-diabetogenic allele on each QTL. For the diabetic QTL on Chr. 10 ( T2dm1sa ), the chromosomal region including this locus from SM/J mice was introgressed into A/J mice. For the diabetic QTL on Chr. 2 or 18, the chromosomal region including each locus from A/J mice was introgressed into SM/J mice. We had already confirmed and reported the diabetogenic effects of the QTL on Chr. 2 using SM.A-T2dm2sa congenic mice fed a high-fat diet ( 11 ) . Therefore, in this study we used two congenic strains established for investigating QTLs on Chr. 10 and 18 in order to examine whether each QTL possesses the diabetogenic gene that affects glucose tolerance when mice are fed either a high-carbohydrate diet or a high-fat diet.
RESEARCH DESIGN AND METHODS
Animals . Parental SM/J and A/J strains were obtained from the Institute for Laboratory Animal Research, Nagoya University School of Medicine (Nagoya, Japan). The A.SM-T2dm1sa and SM.AD18Mit19-D18Mit7 congenic strains were produced as described below in the sections "Production of A.SMT2dm1sa congenic strains" and "Production of SM.AD18Mit19-D18Mit7 congenic strains." All mice were maintained under conventional conditions, in a room kept at a controlled temperature of 23 Ϯ 3˚C and a 12-h light/dark cycle. Starting at 6 wk of age, all mice were provided drinking water and the experimental diet ad libitum. Mice were fed either the high-carbohydrate (HC) diet or high-fat (HF) diet continuously from 6 to 18 wk of age. The composition of the HC and HF diets is presented in Table 1 . The animal care and experimental procedures were approved by the Animal Research Committee of Nagoya University, and all studies were conducted according to the Regulations for Animal Experimentations of Nagoya University. Production of A.SM-T2dm1sa congenic strains . Male A/J mice were mated with SM/J female mice to produce F1 mice. Female F1 mice were backcrossed to A/J males to produce the N2 generation. Male heterozygous carriers of Chr. 10 intervals between D10Mit15 and D10Mit269 were continuously bred with A/J mice to produce the next generation. The marker-assisted speed congenic procedure resulted in Ͼ 99% replacement of the A/J background genome by the N5 generation. N6 congenic animals were intercrossed to produce F1 animals (N6:F1) that were homozygous for the introgressed D10Mit15-D10Mit269 region from SM/J mice. The A.SM-T2dm1sa congenic strain possessed the SM/J homozygous alleles between D10Mit15 (proximal, 66.5 Mb) and D10Mit269 (distal, 128.4 Mb).
Production of SM.A-D18Mit19-D18Mit7 congenic strains . Male SM/J mice were mated with A/J female mice to produce F1 mice. Male F1 mice were backcrossed to SM/J females to produce the N2 generation. Male heterozygous carriers of Chr. 18 intervals between D18Mit19 and D18Mit7 were continuously bred with SM/J mice in order to produce the next generation. The marker-assisted speed congenic procedure resulted in Ͼ 99% replacement of the SM/J background genome by the N5 generation. N6 congenic animals were intercrossed to produce F1 animals (N6:F1) that were homozygous for the introgressed D18Mit19-D18Mit7 region from the A/J. The SM.A-D18Mit19-D18Mit7 congenic strain possessed the A/J homozygous alleles between D18Mit19 (proximal, 5.0 Mb) and D18Mit7 (distal, 77.1 Mb) (Fig. 1) .
Phenotypic characterization . Body weight and analnasal length of the mice were measured at 10 wk of having been fed either diet. Body mass index was calculated as body weight (g) divided by the square of the anal-nasal length (cm). Free-fed blood samples were obtained from mice after 10 wk of having been fed the experimental diets. Serum samples were collected, centrifuged, and stored at Ϫ 30˚C until needed for the assay. Serum insulin concentrations were measured by radioimmunoassay (ShionoRIA; Shionogi, Osaka, Japan). IPGTT was performed using the following protocol after 10 wk of having been fed the experimental diets. After the animals had fasted for 14 h (from 7 pm to 9 am), blood samples were collected from the tail vein (fasting blood glucose samples). Then, a 20% glucose solution was injected into the mice intraperitoneally (2 g glucose/kg body weight). Blood samples were collected 30, 60, and 120 min after the injection. Blood glucose concentrations were measured using the glucose oxidase method (Glucose-B test Kit, Wako Pure Chemical Industries, Ltd., Tokyo, Japan). The AUC was calculated according to the trapezoid rule based on the glucose measurements at fasting, and at 30, 60, and 120 min (mg/dL·min). After a week of IPGTT (fed the experimental diets for 11 wk), all mice were food deprived for 1 h prior to killing and killed by cervical dislocation. The liver, subcutaneous fat, epididymal fat, retroperitoneal fat, and mesenteric fat were dissected and weighed. Subcutaneous fat was defined as fat pads below the root of the forefoot on one side of the body.
Statistical analysis . Data are expressed as means Ϯ SE. Data were analyzed by two-way ANOVA, and values of p Ͻ 0.05 were regarded as significant. If the interaction effect of two components (strain ϫ diet) was significant according to two-way ANOVA, then one-way ANOVA and a subsequent Tukey-Kramer test were carried out to compare the means of all groups. Statistical analyses were performed using StatView version 5.0 software (SAS Institute, Cary, NC). 
RESULTS

Body composition and glucose metabolism in A.SMT2dm1sa congenic mice
Body weight, BMI, and relative fat weights were affected by diet, but not by strain. Only the relative liver weight in A.SM-T2dm1sa congenic mice was significantly lower than that in A/J mice ( Table 2 ). There were no significant differences in blood glucose concentrations at any time point during IPGTT between A/J and A.SM-T2dm1sa congenic mice on either of the experimental diets (Fig. 2) . The free-fed blood glucose concen- tration in A.SM-T2dm1sa congenic mice was significantly lower than that in A/J mice.
Body composition in SM.A-D18Mit19-D18Mit7 congenic mice
When fed the HF diet for 10 wk, SM.A-D18Mit19-D18Mit7 congenic mice and SM/J mice showed increased body weight, BMI, and fat accumulation (Table 3) . Body weight and BMI in SM.A-D18Mit19-D18Mit7 congenic mice were significantly higher than those of SM/J mice (Table 3) . Relative tissue weights of subcutaneous fat, epididymal fat, and retroperitoneal fat in SM.A-D18Mit19-D18Mit7 mice were significantly higher than those in SM/J mice. On the HC diet, but not the HF diet, the relative mesenteric fat weight of SM.A-D18Mit19-D18Mit7 mice was significantly higher than that of SM/J mice.
Glucose metabolism in SM.A-D18Mit19-D18Mit7 congenic mice
The IPGTT results are shown in Fig. 3 . The fasting blood glucose concentration was not affected by strain. In contrast to the HC diet, the HF diet was associated with increased blood glucose concentrations at 30, 60, and 120 min. On either diet, the blood glucose concentration of SM.A-D18Mit19-D18Mit7 mice at all time points after glucose injection was significantly higher than that of SM/J mice. In the IPGTT, the blood glucose concentration at 120 min in SM/J mice fed the HF diet showed a 78% increase compared with that in SM/J mice fed the HC diet. In contrast, the blood glucose concentration at 120 min in SM.A-D18Mit19-D18Mit7 mice fed the HF diet was 13% higher than that of SM.AD18Mit19-D18Mit7 mice fed the HC diet. SM.AD18Mit19-D18Mit7 mice showed higher AUC values on the IPGTT than did SM/J mice, irrespective of the kind of diet they had been fed (Table 3 ). The AUC value upon IPGTT in SM.A-D18Mit19-D18Mit7 mice fed the HC diet was comparable to that in SM/J mice fed the HF diet. The free-fed blood glucose concentration in SM.AD18Mit19-D18Mit7 mice did not significantly differ from that of SM/J mice. On either diet, the free-fed serum insulin concentration in SM.A-D18Mit19-D18Mit7 mice was approximately 100% higher than that of SM/J mice.
DISCUSSION
To confirm the diabetogenic effects of T2dm1sa on Chr. 10 and the QTL at D18Mit20-D18Mit17 on Chr. 18, we established two congenic strains of mice, A.SMT2dm1sa and SM.A-D18Mit19-D18Mit7.
Previously, Anunciado et al. (12) also mapped a QTL for serum insulin concentrations near T2dm1sa on Chr. 10 by QTL analysis using SMXA RI strains fed a chow diet. Unexpectedly, in the present study, the diabetogenic effect of T2dm1sa mapped on Chr. 10 was not confirmed in A.SM-T2dm1sa congenic mice, in contrast to the results obtained with A/J mice. Although the parental strains (SM/J and A/J strains) are non-diabetic, the SMXA-5 strain, i.e., an SMXA RI strain, develops impaired glucose tolerance and hyperinsulinemia (10, 13) . Thus, the combination of diabetogenic genes present in SM/J and A/J mice leads to the development of diabetic traits in SMXA-5 mice. Based on the present results observed in A.SM-T2dm1sa mice, the coexistence of T2dm1sa and other diabetogenic loci within the SM/J genome might be necessary for the development of a diabetic phenotype. We previously mapped diabetes-related QTLs on the proximal Chr. 18 (i.e., the nearest marker, D18Mit20 [14.8 Mb] and D18Mit17 [39.6 Mb]) in mice fed the HC diet ( Fig. 1) (10) . Using (SM/JϫA/J)F2 mice (an intercross between the parental strains) fed a chow diet, a QTL for body weight was detected at D18Mit15 (35.1 Mb) (14) . When the mice received the HF diet, a diabetes-related QTL (T2dm3sa) was detected on the distal Chr. 18 (the nearest marker, D18Mit152 [62. 1 Mb] and D18Mit8 [74.6 Mb]) using an (A/JϫSM.AT2dm2sa)F2 intercross (15) . The QTL mapping results demonstrated that the chromosomal regions controlling diabetes-related traits differed with the experimental diet used in the phenotype analysis (10, 14, 15) . In this study, we had constructed an A.SM-D18Mit19-D18Mit7 congenic mouse, in which a wide region of Chr. 18 from A/J mice was introgressed into the SM/J strain. It appears that SM.A-D18Mit19-D18Mit7 congenic mice could be used for analysis of the diabetogenic effects of these QTLs fed either the HC or HF diet. This study demonstrated that a segment of Chr. 18 (18Mit19-D18Mit7; 5.0-77.1 Mb) exerts a significant effect on body weight and BMI, and glucose tolerance in mice fed either the HC or the HF diet. Previously, we performed a QTL analysis in order to analyze the diabetogenic genes present in the A/J genome of SMXA-5 mice by using (SM/JϫSMXA-5)F2 mice fed an HF diet; however, we were unable at the time to detect any diabetic loci on Chr. 18 (11) . SMXA-5 mice possess the A/ J genome interval between D18Mit19 and D18Mit40 (5.0-63.9 Mb) and the SM/J genome interval between D18Mit103 and D18Mit7 (70.4-77.1 Mb). If a diabetic QTL exists within the distal chromosomal region of D18Mit40, we were unable to detect it in our previous analysis using (SM/JϫSMXA-5)F2 mice. Previous and present results, when taken together, suggest that diabetogenic loci might be present in the chromosomal region between D18Mit40 and D18Mit7, and this diabetic phenotype may be expressed when mice are fed an HF diet.
Two QTLs for diabetes-related traits have been reported around the proximal region of Chr. 18 (Fig. 1) . Nidd2, a QTL for free-fed blood glucose concentrations, was mapped at D18Mit60 (32.6 Mb) using (NZOϫ NON)F2 mice (16) fed an HC diet similar to that used in the present study, i.e., a diet containing 51.5% carbohydrates, 4.5% fat, and 21% protein. Bglu10, another QTL for blood glucose concentrations, was mapped at 33 Mb using (NZBϫNZW)F2 mice (17) fed an atherogenic diet. At present, it remains unclear whether or not these phenotypes are induced by a distinct diabetogenic gene.
In conclusion, this study demonstrated the diabetogenic effects of the A/J allele on Chr. 18, as verified by impaired glucose tolerance in SM.A-D18Mit19-D18Mit7 congenic mice. In the future, it would be desirable to produce subcongenic mice, the genome of which would contain a portion of the chromosomal region of D18Mit19-D18Mit7; the chromosomal region affecting diabetes-related traits caused by an HF or HC diet would be the region of interest. It is likely that a functional diabetogenic gene(s) associated with HF and/or HC feeding will be isolated with the help of subcongenic strain analysis. Identifying genes associated with type 2 diabetes induced by a characteristic diet in mice is expected to contribute to the development of novel treatments for human type 2 diabetes, and such studies also promise to facilitate disease prevention.
